Emerging Trends in Global Regulations: Insights Into More Efficient Regulatory Writing Practices
51:16
Overcoming Deadline Bottlenecks in Pharma: How a Writing Team Can Help
1:00:19
Good Science vs. Bad Writing: Strategies for Building an Effective Scientific Writing Team
59:31
Understanding FDA: Essentials for Briefing Books in Pre-IND, Pre-NDA, and Pre-BLA Meetings
52:08
Considerations for Companion Diagnostics: Lessons Learned and Key Takeaways from DIA 2024
50:20
Devices in Focus: How to Save Time & Money with Real World Evidence
1:02:18
How Much Data is “Sufficient”? Navigating Clinical Evidence Requirements Under the MDR and IVDR
36:11
Ask the Expert: The Role of Real-World Evidence (RWE) in Regulatory Submissions
46:15